NCT05209152 AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic Leukemia Status TERMINATED Phase PHASE1
NCT05198934 Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation Status COMPLETED Phase PHASE3
NCT05180422 A Phase I/II Study of AMG 510 in Combination With MVASI in Patients With Advanced, Unresectable or Metastatic KRAS G12C Mutant NSCLC With Asymptomatic Brain Metastasis Status WITHDRAWN Phase PHASE1/PHASE2
NCT05174065 Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP) Status COMPLETED Phase PHASE3
NCT05162027 Erenumab-aooe for Temporomandibular Disorders Management: TMD Cgrp Antibody RElief (TMD CARE) Status TERMINATED Phase PHASE2
NCT05142228 Erenumab-aooe for the Management of Trigeminal Neuropathic Pain. Status TERMINATED Phase PHASE2
NCT05135312 Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging Status UNKNOWN Phase PHASE4
NCT05118854 A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05111626 Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. Status TERMINATED Phase PHASE3
NCT05094336 A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05074810 Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05073315 A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT05062759 Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma Status COMPLETED Phase PHASE3
NCT05060016 A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05056246 Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants Status COMPLETED Phase PHASE1
NCT05054725 Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies Status COMPLETED Phase PHASE2
NCT05052801 Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression Status COMPLETED Phase PHASE3